☰

Eric J. Nunes - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
Depression/dopamine
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Nunes EJ, Addy NA, Conn PJ, Foster DJ. Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric Disorders. Annual Review of Pharmacology and Toxicology. PMID 37552895 DOI: 10.1146/annurev-pharmtox-051921-023858  0.313
2023 Nunes EJ, Kebede N, Haight JL, Foster DJ, Lindsley C, Conn PJ, Addy N. Ventral tegmental area M5 muscarinic receptors mediate effort-choice responding and nucleus accumbens dopamine in a sex-specific manner. The Journal of Pharmacology and Experimental Therapeutics. PMID 36828630 DOI: 10.1124/jpet.122.001438  0.531
2022 Nunes EJ, Kebede N, Bagdas D, Addy NA. Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders. Journal of the Experimental Analysis of Behavior. PMID 35286712 DOI: 10.1002/jeab.747  0.4
2020 Nunes EJ, Rupprecht LE, Foster DJ, Lindsley CW, Conn PJ, Addy NA. Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats. Neuropharmacology. 108089. PMID 32268153 DOI: 10.1016/J.Neuropharm.2020.108089  0.477
2019 Nunes EJ, Bitner L, Hughley SM, Small KM, Walton SN, Rupprecht LE, Addy NA. Cholinergic Receptor Blockade in the VTA Attenuates Cue-Induced Cocaine-Seeking and Reverses the Anxiogenic Effects of Forced Abstinence. Neuroscience. 413: 252-263. PMID 31271832 DOI: 10.1016/J.Neuroscience.2019.06.028  0.444
2018 Addy NA, Nunes EJ, Hughley SM, Small KM, Baracz SJ, Haight JL, Rajadhyaksha AM. The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29773910 DOI: 10.1038/S41386-018-0080-2  0.397
2017 Wickham RJ, Nunes EJ, Hughley S, Silva P, Walton SN, Park J, Addy NA. Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling. Neuropharmacology. PMID 28943284 DOI: 10.1016/J.Neuropharm.2017.09.029  0.385
2016 Small KM, Nunes E, Hughley S, Addy NA. Ventral tegmental area muscarinic receptors modulate depression and anxiety-related behaviors in rats. Neuroscience Letters. 616: 80-85. PMID 26828299 DOI: 10.1016/J.Neulet.2016.01.057  0.534
2015 Wickham RJ, Park J, Nunes EJ, Addy NA. Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats. Journal of Visualized Experiments : Jove. e52468. PMID 26325447 DOI: 10.3791/52468  0.504
2015 Wickham RJ, Solecki WB, Nunes EJ, Addy NA. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues. Neuroscience. 301: 384-94. PMID 26093048 DOI: 10.1016/J.Neuroscience.2015.06.021  0.5
2015 Addy NA, Nunes EJ, Wickham RJ. Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking. Behavioural Brain Research. 291: 372-6. PMID 26026787 DOI: 10.1016/J.Bbr.2015.05.036  0.549
2015 Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists. Pharmacology, Biochemistry, and Behavior. 135: 217-26. PMID 26022661 DOI: 10.1016/J.Pbb.2015.05.003  0.562
2015 Addy NA, Nunes EJ, Wickham RJ. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test. Behavioural Brain Research. 288: 54-62. PMID 25865152 DOI: 10.1016/J.Bbr.2015.04.002  0.544
2015 Wickham RJ, Park J, Nunes EJ, Addy NA. Examination of rapid dopamine dynamics with fast scan cyclic voltammetry during intra-oral tastant administration in awake rats Journal of Visualized Experiments. 2015. DOI: 10.3791/52468  0.316
2015 Wickham RJ, Solecki WB, Nunes EJ, Addy NA. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues Neuroscience. 301: 384-394. DOI: 10.1016/j.neuroscience.2015.06.021  0.315
2014 Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Plos One. 9: e99320. PMID 24937131 DOI: 10.1371/Journal.Pone.0099320  0.564
2014 Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology. 231: 727-36. PMID 24136220 DOI: 10.1007/S00213-013-3285-4  0.42
2013 Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19120-30. PMID 24305809 DOI: 10.1523/Jneurosci.2730-13.2013  0.568
2013 Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 250: 507-19. PMID 23867769 DOI: 10.1016/J.Neuroscience.2013.07.008  0.443
2013 Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neuroscience and Biobehavioral Reviews. 37: 2015-25. PMID 23583616 DOI: 10.1016/J.Neubiorev.2013.04.002  0.641
2013 Salamone JD, Nunes EJ, Randall PA, Yohn SE, Merce C. S.2.1 - DEVELOPMENT OF ANIMAL MODELS OF THE EFFORT-RELATED SYMPTOMS OF DEPRESSION Behavioural Pharmacology. 24: e3. DOI: 10.1097/01.Fbp.0000434686.35248.7A  0.31
2012 Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One. 7: e47934. PMID 23110135 DOI: 10.1371/Journal.Pone.0047934  0.575
2012 Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry, and Behavior. 102: 477-87. PMID 22705392 DOI: 10.1016/J.Pbb.2012.06.009  0.516
2012 Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M. The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. Journal of the Experimental Analysis of Behavior. 97: 125-46. PMID 22287808 DOI: 10.1901/Jeab.2012.97-125  0.587
2011 Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216: 173-86. PMID 21347642 DOI: 10.1007/S00213-011-2198-3  0.483
2010 Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacology, Biochemistry, and Behavior. 97: 179-84. PMID 20713079 DOI: 10.1016/J.Pbb.2010.07.021  0.473
2010 Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD. Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience. 170: 268-80. PMID 20600675 DOI: 10.1016/J.Neuroscience.2010.05.068  0.578
2010 Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience. 166: 1056-67. PMID 20096336 DOI: 10.1016/J.Neuroscience.2009.12.056  0.602
2010 Salamone JD, Correa M, Farrar AM, Nunes EJ, Collins LE. Role of dopamine-adenosine interactions in the brain circuitry regulating effort-related decision making: Insights into pathological aspects of motivation Future Neurology. 5: 377-392. DOI: 10.2217/Fnl.10.19  0.54
2009 Salamone JD, Correa M, Farrar AM, Nunes EJ, Pardo M. Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience. 3: 13. PMID 19826615 DOI: 10.3389/Neuro.08.013.2009  0.58
2009 Sink KS, Segovia KN, Nunes EJ, Collins LE, Vemuri VK, Thakur G, Makriyannis A, Salamone JD. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology. 206: 223-32. PMID 19588124 DOI: 10.1007/S00213-009-1602-8  0.531
2009 Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behavioural Brain Research. 201: 216-22. PMID 19428636 DOI: 10.1016/J.Bbr.2009.02.021  0.564
2009 Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Müller CE, Salamone JD. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology. 204: 103-12. PMID 19132351 DOI: 10.1007/S00213-008-1441-Z  0.592
Show low-probability matches.